Actemra

Links shared publicly online about this topic

Actemra « Rheumatoid Arthritis Guy

rheumatoidarthritisguy.com — “Actemra « Rheumatoid Arthritis GuyView full resource at rheumatoidarthritisguy.com

  • View Related
  • Share

Most Recently Shared on January 9, 2010 at 5:07 am By:

RA_Guy RA Guy Patient Expert

U.S. approves Roche’s Actemra arthritis drug http://bit.ly/8kbo6u

2 years ago...

ACTEMRA (tocilizumab) | Rheumatoid Arthritis Treatment

actemra.com — “Find information about ACTEMRA, an FDA-approved treatment for rheumatoid arthritis. ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well. ACTEMRA is used to treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older. SoView full resource at actemra.com

  • View Related
  • Share

Most Recently Shared on January 20, 2012 at 3:35 pm By:

FDA Grants Supplemental Approval for Actemra (tocilizumab)

drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 8, 2011 at 7:10 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Grants Supplemental Approval for Actemra (tocilizumab): SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--... http://bit.ly/hYVEcs #drug

1 year ago...

FDA approves Roche's Actemra | InPharm

inpharm.com — “FDA approves Roche's Actemra | InPharmView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on January 11, 2010 at 11:15 am By:

Pharmafocus Pharmafocus Health News and Pharma

FDA approves Roche’s Actemra. RA treatment will launch in the US next week with second-line licence. http://ow.ly/V2sT

2 years ago...

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

twurl.nl — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at twurl.nl

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 11:36 am By:

Stroke_News News-Medical.Net Health News

Stroke News: ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member ... http://twurl.nl/6p6ovr

2 years ago...

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 12:41 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/dbhtqB

2 years ago...

FDA Approves Actemra for Treatment of Rheumatoid Arthritis

emaxhealth.com — “Yesterday, Genetech Inc (a subsidiary of the Roche Group) announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizuma...View full resource at emaxhealth.com

  • View Related
  • Share

Most Recently Shared on January 9, 2010 at 7:00 pm By:

ksmithdc Dr. Kevin Smith Doctor, CAM, and Chiropractor

FDA Approves Actemra for Treatment of Rheumatoid Arthritis ...: Yesterday, Genetech Inc (a subsidiary of the Ro.. http://bit.ly/5oOGXA

2 years ago...

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 7:28 am By:

NewsMedical News-Medical.Net Health News

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/a270wI

2 years ago...

Actemra: 38% of rheumatologists have commenced treatment

news-medical.net — “BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 3, 2010 at 1:48 pm By:

NewsMedical News-Medical.Net Health News

Actemra: 38% of rheumatologists have commenced treatment: BioTrends Research Group released topline findings from ... http://bit.ly/9HIbwf

2 years ago...

FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 12, 2010 at 12:27 am By:

drugscom Drugs.com Health Site

FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion

2 years ago...

FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)

drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 19, 2011 at 3:15 am By:

drugscom Drugs.com Health Site

FDA Approves Actemra for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA) - http://bit.ly/gKMQJR

1 year ago...

FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)

drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 19, 2011 at 4:12 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA): SOU... http://bit.ly/h7x9uE #drug

1 year ago...

Roche gets FDA nod for broader Actemra use | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. health regulators on Friday approved Roche Holding AG's rheumatoid arthritis drug Actemra for treating a rare form of juvenile arthritis.Roche has been trying to expand theView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 15, 2011 at 10:32 pm By:

MedicalNews Medical News Health News

Roche gets FDA nod for broader Actemra use http://bit.ly/e3Tqku

1 year ago...

Roche gets FDA nod for broader Actemra use | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. health regulators on Friday approved Roche Holding AG's rheumatoid arthritis drug Actemra for treating a rare form of juvenile arthritis.Roche has been trying to expand theView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 16, 2011 at 12:22 am By:

Roche gets FDA nod for broader Actemra use | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. health regulators on Friday approved Roche Holding AG's rheumatoid arthritis drug Actemra for treating a rare form of juvenile arthritis.Roche has been trying to expand theView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 15, 2011 at 8:46 pm By:

Bradmed Brad Lipson, DO Doctor, Family Medicine Doctor, Physician, and Active Health Library

Roche gets FDA nod for broader Actemra use: WASHINGTON (Reuters) - U.S. health regulators on Friday approv... http://tinyurl.com/3hovkmt

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • RA_Guy

    RA Guy

    Adventures of a superhero on his journey through chronic pain and debilitating inflammation

    View Profile

  • NicoleKinseyOW

    Nicole Kinsey

    I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.

    I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.

    I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.

    I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.

    View Profile

  • Drugs_Devices

    Drugs and Devices OW

    Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390